오가논 & Co (OGN)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 배당 이력

Relative Volume:

오가논 & Co Stock (OGN) Company Profile

Healthcare (1113)

551-430-6000

30 HUDSON STREET, JERSEY CITY

최신 SEC 제출 서류

OGN's Discussions on Twitter

Compare OGN vs LLY, JNJ, ABBV, AZN, NVS

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
OGN Organon Co	9.20	2.30B	6.22B	187.00M	508.00M	0.7166
LLY Lilly Eli Co	919.45	806.72B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	226.91	544.73B	96.36B	21.04B	19.70B	8.6488
ABBV Abbvie Inc	205.01	362.81B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	196.01	303.62B	58.80B	10.24B	8.98B	3.2788
NVS Novartis Ag Adr	147.98	282.35B	54.72B	14.02B	15.32B	7.1855

오가논 & Co Stock (OGN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-12-09	개시	Barclays	Underweight
2025-10-27	다운그레이드	Piper Sandler	Overweight → Underweight
2025-05-02	다운그레이드	Evercore ISI	Outperform → In-line
2024-09-06	다운그레이드	JP Morgan	Neutral → Underweight
2023-11-03	다운그레이드	Goldman	Buy → Neutral
2023-09-21	개시	Barclays	Overweight
2023-03-16	개시	Raymond James	Outperform
2022-10-14	다운그레이드	BofA Securities	Neutral → Underperform
2022-09-06	업그레이드	Piper Sandler	Neutral → Overweight
2022-08-05	다운그레이드	BofA Securities	Buy → Neutral
2022-04-27	개시	Goldman	Buy
2022-04-06	재개	Morgan Stanley	Equal-Weight
2021-10-07	개시	Piper Sandler	Neutral
2021-09-01	개시	BofA Securities	Buy
2021-07-22	개시	Citigroup	Buy
2021-06-15	개시	JP Morgan	Neutral
2021-06-11	개시	Morgan Stanley	Equal-Weight
2021-06-10	개시	Evercore ISI	Outperform

오가논 & Co 주식(OGN)의 최신 뉴스

오가논 & Co (OGN) 재무 분석

오가논 & Co (OGN)

오가논 & Co Stock (OGN) Company Profile

Compare OGN vs LLY, JNJ, ABBV, AZN, NVS

오가논 & Co Stock (OGN) Upgrades & Downgrades

오가논 & Co 주식(OGN)의 최신 뉴스

Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage - MSN

What does Sun Pharma gain from its $12-billion Organon bid? - MSN

Organon (OGN) Is Up 8.4% After VTAMA Wins Key Steroid-Free Role In New Pediatric Guidelines - simplywall.st

Why Organon (OGN) Drew Buyout Buzz After a Sharp Repricing - Yahoo Finance

Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility - MSN

Organon & Co (OGN) Stock Price Quote Today & Current Price Chart - Capital.com

Organon rises as Sun Pharma said to near $12B buyout deal - MSN

This women’s health company is drawing takeover interest. The stock is soaring. - MSN

Notable healthcare headlines for the week: J&J, Abbott and Organon in focus - MSN

Organon & Co. Soars 17.92% to Hit Intraday High of USD 6.96 - Markets Mojo

Organon gains as Sun Pharma, Grünenthal said to seek takeover deals - MSN

Organon (OGN) stock drops despite market gains: Important facts to note - MSN

Sun Pharma preps for Organon bid - ifr-logo

Healthcare Sector Analysis: Organon & Co. (OGN) Leads with Low F - GuruFocus

Organon (OGN) rises higher than market: Key facts - MSN

Organon (OGN) Rises Higher Than Market: Key Facts - Yahoo Finance

Organon (OGN) Shares Rise as Sun Pharma and Grünenthal Eye Acqui - GuruFocus

Organon & Co. (OGN) Stock Rises 4% to $9.6 - AlphaStreet

Organon & Co. (NYSE:OGN) Shares Gap UpTime to Buy? - MarketBeat

Organon gets buyout interest from Sun Pharma, Grünenthal (OGN) - Seeking Alpha

Press Release: Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026 - 富途牛牛

Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026 - Bluefield Daily Telegraph

Organon & Co. (NYSE:OGN) Upgraded by Zacks Research to "Hold" Rating - MarketBeat

Why Organon (OGN) Is Surging as Buyout Interest Gains Traction - Insider Monkey

Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon - Bloomberg

AAD recommends Organon’s VTAMA cream for pediatric atopic dermatitis - Investing.com

Only steroid-free cream AAD backs for all child eczema severities - Stock Titan

Massachusetts Financial Services Co. MA Cuts Stock Holdings in Organon & Co. $OGN - MarketBeat

Sun Pharma Faces Fresh Organon Acquisition Reports After Official Denial - scanx.trade

Organon & Co. Experiences Evaluation Revision Amidst Mixed Market Indicators and Volatility - Markets Mojo

Organon (OGN) climbs 39% on $12-billion merger buzz - MSN

Organon & Co. (NYSE:OGN) Q4 2025 earnings call transcript - MSN

Organon & Co. Shares Drop 6.4% as Analysts Forecast Weak Growth - National Today

Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

3 Reasons to Avoid OGN and 1 Stock to Buy Instead - Yahoo Finance UK

Organon & Co. (NYSE:OGN) Shares Down 6.4%Time to Sell? - MarketBeat

Unusually active option classes on open April 13th - TipRanks

Organon Takeover At $15? Probably Not, Here's Why (NYSE:OGN) - Seeking Alpha

Organon Stock Skyrockets 28% Following Reports of $12 Billion Buyout Offer From Sun Pharma - TIKR.com

Sun Pharma’s Reported US$12b Bid Recasts Organon’s Risk Reward Profile - Sahm

American pharmaceutical MSD receiving billions in tax benefits in the Netherlands - NL Times

EBIT per share of Organon & Co. – SWB:7XP - TradingView — Track All Markets

Is Organon (OGN) Now An Opportunity After Its Recent Share Price Surge? - Yahoo Finance

Buy or Sell Organon Stock in 2026? Takeover Buzz Lifts Shares 28% as Analysts Stay Cautious - International Business Times Australia

Institutional Money Floods Organon as Analysts Warn and Charts Conflicted - Bitget

Organon (OGN) Climbs 39% on $12-Billion Merger Buzz - Insider Monkey

Key deals this week: Organon, UMG, Whitestone REIT, Gilead and more - Seeking Alpha

Avoiding Lag: Real-Time Signals in (OGN) Movement - Stock Traders Daily

Organon Shares Soar as Sun Pharmaceutical Eyes $12B Deal - timothysykes.com

Morning Movers: Organon jumps after report of Sun Pharmaceutical bid - Yahoo Finance

Morgan Stanley Reaffirms Their Hold Rating on Organon (OGN) - The Globe and Mail

오가논 & Co (OGN) 재무 분석

매출

순이익

현금흐름

주당 순 이익

OGN과 유사한 종목